Qube Research & Technologies (QRT)
LSTA icon

Qube Research & Technologies (QRT)’s Lisata Therapeutics LSTA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,403
Closed -$26K – 2781
2021
Q3 		$26K Buy
+1,403
New +$27.5K ﹤0.01% 1943

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LSTA Position: Q4 2021 in Review

Qube Research & Technologies (QRT) sold out of Lisata Therapeutics (LSTA) in Q4 2021, closing a stake of 1,403 shares — an estimated $26K sold.

Qube Research & Technologies (QRT) first reported a position in LSTA in Q3 2021 and held it in 1 quarter. The position peaked at $26K in Q3 2021. 34 funds tracked by Wall St. Rank hold LSTA as of Q4 2021.

  • Qube Research & Technologies (QRT) reported no remaining Lisata Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,403 Lisata Therapeutics shares in Q4 2021, an estimated $26K.
  • Qube Research & Technologies (QRT) first reported a position in Lisata Therapeutics in Q3 2021 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Lisata Therapeutics position peaked at $26K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q4 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2021, filed 1 Feb 2022.